---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-003906"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2023-01-20T23:59:59+00:00"
generated_at: "2026-06-20T12:26:03.990673+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma transmits three PCT patent applications to USPTO for psilocybin delivery

## Summary
- Received notice of successful transmission to USPTO for three PCT patent applications.
- Applications filed July 2021 relate to CNS-homing peptides delivering anti-inflammatory therapeutics with psilocybin.
- National phase entries for these PCT applications are now at the USPTO.

## SEC filing metadata
- accession: 0001213900-23-003906
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2023-01-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390023003906/0001213900-23-003906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390023003906/ea171925-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-003906
- JSON: https://secwatch.observer/filing/0001213900-23-003906.json
- Plain text: https://secwatch.observer/filing/0001213900-23-003906.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.